Delivery Order SPE2DB22D3301-SPE2DB24FY8YC

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,359,320 units of Vyvanse 50 mg capsules. The contract has a ceiling value of $4,006.50 and is a firm-fixed price delivery order, with a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor and healthcare solutions provider) is for the delivery of Vyvanse 30 mg capsules over a period ending on November 4, 2024. The contract, valued at $1,947.26, was awarded by the Defense Logistics Agency (DLA), a defense agency, on November 1, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,178.84 firm fixed-price delivery order is for the supply of 4,564,402,700 units of the prescription drug Vyvanse (60 mg capsules). The contract has an ultimate completion date of April 24, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Vyvanse capsules (50mg) and other medical products and prescription drugs. The contract has a ceiling value of $13,067.09 and is a firm fixed price delivery order valid through June 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules. The contract has a ceiling value of $4,772.48 and a completion date of May 23, 2024. It is a firm fixed price delivery order contract without any set-aside designations. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse capsules (30mg) over a period ending on May 14, 2024. The contract has a ceiling value of $95,027.20 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen, through its Corporate Office division, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the delivery of 4,564,754,929 units of Vyvanse 30mg capsules. The contract has a ceiling value of $3,605.52 and is a Delivery Order with a Firm Fixed Price pricing type. The contract has a period of performance through May 31, 2024 and was awarded on May 30, 2024. This appears to be a direct award without a set-aside designation. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,830.77 firm fixed-price delivery order is for the supply of 4,566,487,709 units of the drug Vyvanse 40 mg capsules. The award has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,724.00 firm fixed price delivery order is for the supply of 100 units of the medication Vyvanse 50 mg capsules. The contract has a completion date of May 14, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver Vyvanse 30 mg capsules. The $1,016.90 firm fixed-price delivery order has a completion date of July 3, 2024 and was awarded on July 2, 2024. This award is a part of AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY8YC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vyvanse 30 mg capsules. The contract has a firm fixed price, ceiling value of $1,121.72, and a completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/19/24, 9:16 AM